BLK chart, page-440

First 440 Last

Share
Profile

Follow
Evfletcher

741 Posts.

215

06/07/18

12:32

Post #: 34186077
Share

Originally posted by Bludog ↑

Hi E, I think you raise a very interesting sub question here...I am not sure but the current cost base includes two types of costs...the costs to get to a 100,000 oz producer...AND the costs of drilling/next plan of getting from lets say 100,000 oz to 200,000 oz.

To me the first is acting like a "producer" ,the second are costs acting like an "explorer" (ie yet to get the benefit of producer income). We see and can forecast the future income side of the longer term potential.... But I do suspect that the ASIC does include the second type of costs (for some accounting or reporting reasons).
Your point may be correct, IF these "second" type costs are included in ASIC (as they may have to be) and IF the market is only pricing on the shorter term income outlook, there may be "Hiddenvalue" there. This could be by overestimating the costs that generate current income or by having a higher short term cash flow opportunity (ie your suggestion).
Net net you are correct with the question. I for one do not really understand the underlying cost base components , the trend or potential on the information disclosed. ... but the outlook does look very promising either way. Cheers.

Expand

I agree if exploratory drilling is included in ASIC , this can explain previous high ASIC. Reduction in drilling and increased gold production (decreased fixed cost) will see significant reduction in ASIC. With reduced debt, positive cash flow, reduced ASIC, higher gold production, high proven reserves, increasing US gold price and a weakening Aussie dollar there isn't a lot to dislike about the future of this company IMO

BLK Price at posting: 6.9¢ Sentiment: Buy Disclosure: Held
3 Upvote

0 Great analysis

Reply

Top Stories

NEC

Nine Entertainment announces its CEO is stepping down – on an ex-divvy day

3 stocks with antimony news on Thursday

SS1

Sun Silver confirms high-grade extension theory at Maverick Springs with 79.6 g/t intercept

DXB

Dimerix begins recruiting young kidney disease patients in Mexico for Phase 3

CU6

Clarity progresses SECuRE trial with positive safety results